Acute myeloid leukemia Archives

News & Features

Precigen’s AML Candidate Gets Fast Track Designation from FDA

Chris Anderson -

April 4, 2022

An illustration of a CRISPR-Cas9 gene editing protein cutting a DNA helix

News & Features

Intellia’s AML Drug Candidate Gets Orphan Drug Designation

Chris Anderson -

March 10, 2022

News & Features

High Iron Level in KRAS Cancer Cells Can Help Target Treatment

Sophia Ktori -

March 10, 2022

News & Features

New High-Risk Mutation Found in Nearly Ten Percent of Relapsed Pediatric AML

Chris Anderson -

February 23, 2022

News & Features

Intellia Acquires Rewrite in Deal Worth Up to $200M

Malorye Branca -

February 4, 2022

News & Features

FDA Puts Five Trials of Gilead Cancer Candidate Magrolimab on Partial Hold

Alex Philippidis -

January 26, 2022

News & Features

Acute Myeloid Leukemia Cells Rely on Little Known Protein for Survival

Helen Albert -

January 11, 2022

News & Features

DNA Study Detects Children with High-Risk AML

Malorye Branca -

August 9, 2021

Epic Sciences is partnering with four Canadian breast cancer centers to carry out a clinical validation trial of the company’s blood test

News & Features

Mutations in Gene Linked to Acute Myeloid Leukemia Can Drive Other Blood Disorders

Helen Albert -

January 15, 2021

News & Features

Invivoscribe Expands into Drug Development with Domainex Licensing Deal

Alex Philippidis -

July 15, 2020

123 4 Page 2 of 4

Ultra-Low Energy MRI Shows Its Potential

Personal Vaccine Combined with Immune-Boosting Agent Improves Treatment of Malignant Glioma

DeepMind’s Next-Gen Protein Structure Predictor AlphaFold 3 Released

AI Improves Prostate Cancer Recurrence Prediction

Targeting Iron Uptake Shows Promise for Treating Asthma and Other Allergic…

Acute myeloid leukemia

Precigen’s AML Candidate Gets Fast Track Designation from FDA

Intellia’s AML Drug Candidate Gets Orphan Drug Designation

High Iron Level in KRAS Cancer Cells Can Help Target Treatment

New High-Risk Mutation Found in Nearly Ten Percent of Relapsed Pediatric AML

Intellia Acquires Rewrite in Deal Worth Up to $200M

FDA Puts Five Trials of Gilead Cancer Candidate Magrolimab on Partial Hold

Acute Myeloid Leukemia Cells Rely on Little Known Protein for Survival

DNA Study Detects Children with High-Risk AML

Mutations in Gene Linked to Acute Myeloid Leukemia Can Drive Other Blood Disorders

Invivoscribe Expands into Drug Development with Domainex Licensing Deal

Related Content

Personal Vaccine Combined with Immune-Boosting Agent Improves Treatment of Malignant Glioma

Altering CAR Proteins Improves T Cells’ Ability to Attack Solid Tumors

New Immune Mechanism That Interferes with Checkpoint Inhibitors Revealed

Cancer-Like Features in Atherosclerosis Provide New Opportunity for Treatment